Viewing StudyNCT06390774



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06390774
Status: RECRUITING
Last Update Posted: 2024-04-30
First Post: 2024-04-08

Brief Title: A Study to Evaluate the Safety Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Sponsor: Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization: Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Conditions & Keywords Data

Conditions:
Name
Locally Advanced Recurrent or Metastatic Malignancies
Keywords:
Name View
advanced malignancies View